• Home
  • Search Results

Search Results

Young Adult (18-34)
2341 studies match your search
Open

Study for a new treatment for a type of blood cancer, Acute Myeloid Leukemia (AML)

Do you have Acute Myeloid Leukemia (AML) and want to try a new study drug that might help treat your cancer?

Age & Gender
  • 18 years ~ 60 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Coming Soon

AYA WELL

We are doing this study to test a behavioral weight loss program designed specifically for adolescent and young adult cancer survivors. Study participants will use technology, including a digital smart scale, Fitbit activity tracker, and study web app to help them lose weight.

Age & Gender
  • 18 years ~ 39 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Obesity
  • Movement
  • and 2 more
Visit Location
100% Remote (online, phone, text)
Coming Soon

A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer

The goal of this research study is to test a new study treatment for a specific type of stomach cancer. It is focused on people whose tumors are CLDN18.2 positive, PD-L1 positive, and HER2 negative. This new study treatment has 3 parts: 1. A study drug called zolbetuximab 2. Another study drug called pembrolizumab 3. Standard chemotherapy (mFOLFOX or CAPOX) Researchers want to know if this combination is safe and if it works better than current treatments for people living with this specific type of stomach cancer

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Colorectal)
Open

Zilovertamab Vedotin+R-CHP vs Polatuzumab Vedotin+R-CHP for 1L DLBCL, GCB

Have you been diagnosed with GCB Subtype of Diffuse LargeB-cell Lymphoma (DLBCL)? If so, you may be able to take part in a research study looking at Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

Studying Updates in neuroCognition after Knee manipulation

Do you feel that your reaction time has slowed after your ACL injury? Has your ability to make decisions on the field/gym/court been impacted? If so, you may be eligible for a study examining the effect a quick joint manipulation has on your reaction time and decision making abilities after your ACL injury.

Age & Gender
  • 18 years ~ 35 years
  • Male, Female, Gender Inclusive
Study Interest
  • Alternative or Complementary Medicine
  • Bones, Joints, Muscles
  • Brain, Head, Nervous System
  • Injury/Injury Prevention
Visit Location
Open

Exploring Sickle Cell and Blood Cells Study

Do you want to help others with sickle cell? Join us in learning more about blood health. By taking part in our study, you may help us discover new ways to treat blood disorders like sickle cell disease. Your participation could bring hope to many. Plus, you'll receive compensation for your time.

Age & Gender
  • 7 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Chronic Conditions
  • Pain
Open

Kidney Health Study

Do you or your child have a kidney condition and take certain meds? Join our study and help us make a difference! You'll also get paid for your time.

Age & Gender
  • 12 years ~ 80 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
Not currently enrolling

Teen Stress and Loss of Enjoyment Study

We want to understand how the brain and the body's stress responses contribute to anhedonia (the loss of enjoyment) in teens over time. Our big question is whether different patterns of activity in the brain and body are linked to loss of enjoyment, and how they change over time.

Age & Gender
  • 13 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Child and Teen Health
  • Healthy Volunteer or General Population
  • and 6 more
Coming Soon

Evaluating Combinations of Medications After Stem Cell Transplant to Prevent Graft versus Host Disease and Infections

The purpose of this study is to look at combinations of medicines given after a stem cell transplant and see how well the combinations work to prevent graft versus host disease and infection.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Other Cancers, Leukemia, Lymphoma)
  • Transplant
Open

Birth Control Media Study

Join our study on how people learn about birth control through news and social media. Share your experience to help improve healthcare communication! We welcome Gen Z'ers from all backgrounds to share their stories.

Age & Gender
  • 18 years ~ 30 years
  • Female, Gender Inclusive
Study Interest
  • Alternative or Complementary Medicine
  • Eating, Nutrition, and Metabolism
  • Healthy Volunteer or General Population
  • and 9 more
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research